CymitQuimica logo

5-Hydroxy flunixin

CAS:

Ref. 3D-FH24012

1mg
651.00€
2mg
1,003.00€
5mg
1,802.00€
10mg
2,925.00€
500µg
439.00€
5-Hydroxy flunixin
Biosynth

    Product Information

    Name:5-Hydroxy flunixin
    Synonyms:
    • 5-Hydroxy-2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid
    Brand:Biosynth
    Description:Flunixin is a nonsteroidal anti-inflammatory drug that is eliminated in the urine. The terminal half-life of flunixin and its metabolite, 5-hydroxyflunixin, are approximately 2 hours and 4 hours, respectively. Flunixin has a linear calibration curve with an R2 value of 0.9993. This drug can be quantified using liquid chromatography tandem mass spectrometry (LC-MS/MS) by preparing the sample with sodium carbonate to hydrolyze any ester groups to the corresponding acid form and then using LC-MS/MS to detect the parent compound and metabolite. The limit of detection for flunixin is 10 ng/mL; the limit of quantification is 20 ng/mL. The concentration of flunixin was found to be 0.14 ± 0.03 µg/mL in human food samples that were analyzed by this method.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:312.24 g/mol
    Formula:C14H11F3N2O3
    Purity:Min. 95%
    Color/Form:Powder

    Technical inquiry about: 5-Hydroxy flunixin

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.